Tag archive for ‘CDMO’
Danaher to acquire US CDMO Aldevron for $9.6bn
By businessnewstoday On Saturday, June 19th, 2021
0 Comments

Danaher to acquire US CDMO Aldevron for $9.6bn

Danaher Corporation has agreed to acquire Aldevron, a North Dakota-based manufacturer of plasmid DNA, mRNA, and recombinant proteins, for nearly $9.6 billion from EQT Group’s EQT VIII fund (EQT Private Equity) More...

Fujifilm cell culture manufacturing facility to come up in Holly Springs, North Carolina
By businessnewstoday On Friday, March 19th, 2021
0 Comments

Fujifilm cell culture manufacturing facility to come up in Holly Springs, NC

Fujifilm has selected Holly Springs of North Carolina as the location for its new $2 billion cell culture manufacturing facility in the US. In January 2021, the Japanese conglomerate announced setting up such a More...

By pharmanewsdaily On Tuesday, December 15th, 2020
0 Comments

EQT offers to acquire Swedish CDMO Recipharm for $2.8bn

Swedish private equity company EQT Partners has offered to takeover Recipharm, a Swedish pharma contract development and manufacturing organization (CDMO), for SEK 23.6 billion ($2.82 billion). As per the terms More...

By pharmanewsdaily On Friday, July 24th, 2020
0 Comments

Novavax NVX-CoV2373 COVID-19 vaccine candidate to be manufactured by FDB

Novavax has signed an agreement with FUJIFILM Diosynth Biotechnologies (FDB), a US-based contract development and manufacturing organization (CDMO), for the manufacturing of bulk drug substance for NVX-CoV2373, More...

By pharmanewsdaily On Tuesday, June 30th, 2020
0 Comments

India-based Piramal Pharma secures $490m investment from Carlyle Group

The Carlyle Group has signed a deal worth around $490 million with Piramal Enterprises, to acquire a stake of 20% from the Indian conglomerate’s pharma business – Piramal Pharma. The US-based private More...

By pharmanewsdaily On Saturday, June 20th, 2020
0 Comments

Piramal Pharma acquires solid oral dosage drug product facility in Sellersville

Piramal Pharma Solutions has agreed to acquire the solid oral dosage drug product manufacturing facility of G&W Laboratories in Sellersville, Pennsylvania for an undisclosed price. A subsidiary of India-based More...

By pharmanewsdaily On Wednesday, March 18th, 2020
0 Comments

Japanese group AGC offers €240m bid for Italian biotech company Molmed

Japanese conglomerate AGC has offered a takeover bid of €240 million to acquire 100% of Italian biotech company cum contract development and manufacturing organization (CDMO) Molecular Medicine (Molmed), valuing More...

By pharmanewsdaily On Tuesday, February 18th, 2020
0 Comments

WuXi vaccine manufacturing facility in Ireland gets $3bn contract

Chinese CDMO WuXi Vaccines has signed a 20-year contract worth around $3bn with an undisclosed vaccine company to use a dedicated vaccine manufacturing facility in Ireland to supply commercial vaccine products manufactured More...

By pharmanewsdaily On Tuesday, February 11th, 2020
0 Comments

Catalent Pharma Solutions acquires cell and gene therapy CDMO MaSTherCell

Drug manufacturer Catalent Pharma Solutions has wrapped up its previously announced $315 million acquisition of MaSTherCell Global, a technology-focused cell and gene therapy contract development and manufacturing More...

By pharmanewsdaily On Wednesday, November 20th, 2019
0 Comments

Recipharm to acquire British CDMO Consort Medical for £505m

Recipharm acquisition of Consort Medical : Swedish pharma group Recipharm has agreed to acquire Consort Medical, a British contract development and manufacturing organization (CDMO) for £505 million, as per the More...